JNJ - Johnson & Johnson
| Previous Close | 139.38 |
| Open | 139.35 |
| Bid | 139.67 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 137.95 - 139.74 |
| 52 Week Range | 121.00 - 148.59 |
| Volume | 4,771,041 |
| Avg. Volume | 7,258,307 |
| Market Cap | 367.778B |
| Beta (3Y Monthly) | 0.70 |
| PE Ratio (TTM) | 26.62 |
| EPS (TTM) | 5.24 |
| Earnings Date | Jan 21, 2020 |
| Forward Dividend & Yield | 3.80 (2.72%) |
| Ex-Dividend Date | 2019-11-25 |
| 1y Target Est | 150.78 |
- PR Newswire
/C O R R E C T I O N -- Johnson & Johnson/
Johnson & Johnson (NYSE: JNJ) announced today that Hubert Joly, Executive Chairman of Best Buy Co., Inc, and Mark A. Weinberger, Former EY Global Chairman and CEO, have been appointed to its Board of Directors.
- MarketWatch
3M, Cisco share losses lead Dow's 75-point fall
DOW UPDATE Shares of 3M and Cisco are retreating Thursday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M (MMM) and Cisco (CSCO) are contributing to the blue-chip gauge's intraday decline, as the Dow (DJIA) was most recently trading 79 points, or 0.
- Zacks
J&J Stock Witnesses Volatility in '19: What to Expect in 2020
Here we discuss the ups and downs of J&J's (JNJ) stock this year.
- Investor's Business Daily
Abbott Is One Of The Biggest Medical Stocks — Should You Buy ABT Stock Now?
ABT stock is one of the biggest diversified medical stocks behind Johnson & Johnson and Roche. As it aims for clearance of its Freestyle Libre 2, is it time to buy Abbott stock?
- Reuters
UPDATE 2-Half a million Ebola vaccine doses to be stockpiled for emergency use
A stockpile of 500,000 doses of Ebola vaccine for emergency use in outbreaks of the deadly fever is being established by the global vaccine alliance GAVI. The plan is for poor and middle-income countries to access the $178 stockpile free of charge, GAVI said on Thursday, while other countries will need to refund the costs. The stockpiling will start with Merck's newly developed Ervebo vaccine, which won regulatory approval last month.
- Zacks
Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $139.38, moving +1.62% from the previous trading session.
- Reuters
US STOCKS-Wall Street bounces back on renewed trade optimism
Trump's comments supported a Bloomberg report that the world's two largest economies were closer to agreeing how many tariffs would be rolled back in a "phase one" trade deal. Fears that a stalemate in negotiations could lead to new tariffs taking effect as scheduled on Dec. 15 have dampened market participants' enthusiasm in recent days, with the major U.S. stock averages falling back from last week's record highs.
- Investor's Business Daily
JNJ Stock Rallies As New Testing Rules Out Asbestos In Baby Powder
JNJ stock popped Wednesday after the Dow Jones pharmaceutical company said additional testing found no asbestos in its baby powder. Independent laboratories performed 155 additional tests.
- Investor's Business Daily
Stock Market Gets Shot Of Adrenaline From Trump Trade Remarks; Dow's Apple, Goldman Rally
Fighting off a three-session slump, the stock market rallied after President Trump touted progress in U.S.-China trade talks.
- Reuters
US STOCKS-Wall Street rebounds on renewed U.S.-China trade optimism
Trump's comments supported a Bloomberg report that the world's two largest economies were closer to agreeing how many tariffs would be rolled back in a "phase one" trade deal. Fears that a stalemate in negotiations could lead to new tariffs taking effect as scheduled on Dec. 15 have made market participants more risk averse in recent days, with the major U.S. stock averages backing off last week's record highs.
- Barrons.com
Johnson & Johnson Says the Government Was Wrong About Asbestos In Baby Powder — and Its Stock Is Rising
Shares of the pharmaceutical giant rose after the company said extensive tests had found no asbestos in the bottle of baby powder in which the Food and Drug Administration found asbestos in October. Johnson & Johnson stock has risen 1.5%.
- Investor's Business Daily
Stocks Bounce Broadly; J&J Breaks Out, But Is The Chart In Trouble?
Stocks held gains in early afternoon trading, as small-cap and semiconductor stocks led a broad rebound in the stock market Wednesday.
- Reuters
US STOCKS-Renewed hopes of trade deal push Wall Street higher
Wall Street was set to break a three-day losing streak on Wednesday, following a report that the United States and China were moving closer to signing a "phase one" trade deal. Washington and Beijing were close to agreeing on the amount of tariffs to be rolled back, Bloomberg reported, a day after President Donald Trump said the deal might have to wait until after the U.S. presidential election in November 2020. "I think the President wants and needs a trade deal before the election, not after," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Company.
- Investor's Business Daily
Dow Jones Jumps 200 Points As China News Fuels Stock Market Rally
The Dow Jones Industrial Average led as key indexes scored solid gains in the stock market today amid renewed optimism for a U.S.-China trade deal.
- Reuters
US STOCKS-Wall Street bounces on trade deal hopes
Wall Street's main indexes looked set to break a three-day losing streak on Wednesday, following a report that the United States and China were moving closer to signing a "phase one" trade deal. Washington and Beijing are getting close to agreeing on the amount of tariffs to be rolled back, Bloomberg reported, a day after President Donald Trump said the deal might have to wait until after the U.S. presidential election in November 2020. "I think the President wants and needs a trade deal before the election, not after," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Company.
- Investor's Business Daily
New Tests Find No Asbestos In J&J Baby Powder — Is JNJ Stock A Safe Buy?
JNJ stock topped a buy point. But several lawsuits claiming Johnson & Johnson baby powder caused cancer are weighing on shares. So, is the Dow Jones component a buy right now?
- Reuters
US STOCKS-Wall St rises on renewed hopes of trade deal
Wall Street's main indexes rose for the first time in four sessions on Wednesday, following a report that the United States and China were moving closer to signing a 'phase-one' trade deal. Washington and Beijing are getting close to agreeing on the amount of tariffs to be rolled back, Bloomberg reported, a day after comments from President Donald Trump and Commerce Secretary Wilbur Ross dampened hopes of a possible near-term agreement.
- Zacks
AstraZeneca Sells Schizophrenia Drug Rights in US and Canada
AstraZeneca (AZN) divests commercial rights to its schizophrenia and bipolar disorder medicines Seroquel/Seroquel XR in the United States and Canada to Cheplapharm Arzneimittel GmbH.
- MarketWatch
Dow's nearly 175-point jump highlighted by gains in shares of Dow Inc., Johnson & Johnson
DOW UPDATE The Dow Jones Industrial Average is trading up Wednesday morning with shares of Dow Inc. and Johnson & Johnson leading the way for the price-weighted average. Shares of Dow Inc. (DOW) and Johnson & Johnson (JNJ) are contributing to the blue-chip gauge's intraday rally, as the Dow (DJIA) is trading 171 points (0.
- Reuters
US STOCKS-Wall St set for higher open as report rekindles hopes of trade deal
Wall Street's main indexes were on course to snap a three-day losing streak on Wednesday, following a report that the United States and China were moving closer to signing a 'phase-one' trade deal. Washington and Beijing are getting close to agreeing on the amount of tariffs to be rolled back, Bloomberg reported on Wednesday, a day after comments from President Donald Trump and Commerce Secretary Wilbur Ross dampened hopes of a possible near-term agreement. The comments had pushed all the three major stock indexes further away from last week's record highs that were fueled by optimism that an interim deal between the two countries was in the works.
- Zacks
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders
J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
- TheStreet.com
Johnson & Johnson Says Government Is Wrong About Asbestos in Its Baby Powder
The FDA said in October it found the presence of sub-trace levels of asbestos contamination in the company's baby powder product.
- Reuters
UPDATE 1-J&J says new tests show no asbestos in Johnson's Baby Powder
Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after U.S. Food and Drug Administration investigations reported trace amounts of the material in the product earlier this year. A total of 155 tests were conducted by two different third-party labs using four different testing methods on samples from the same bottle tested by the FDA's contracted lab, the company said. The tests are the latest effort by J&J to prove the safety of its widely used consumer product after the test by the FDA prompted J&J to undertake a nationwide recall of one lot of Johnson's Baby Powder in October.
- Reuters
J&J says new tests show no asbestos in Johnson's Baby Powder
A total of 155 tests were conducted by two different third-party labs using four different testing methods on samples from the same bottle tested by the FDA's contracted lab, the company said. The tests are the latest effort by J&J to prove the safety of its widely used consumer product after the test by the FDA prompted J&J to undertake a nationwide recall of one lot of Johnson's Baby Powder in October.
Reuters VideosWall Street rebounds on trade hopes
Stocks on Wall Street rose for the first time in four sessions Wednesday. Spurring them higher: President Donald Trump's remarks that trade talks with China were going "very well." Energy stocks led the broad-based rally, pushing the S&P 500 up more than half percent. Edward Jones investment strategist, Nela Richardson: SOUNDBITE: EDWARD JONES INVESTMENT STRATEGIST, NELA RICHARDSON (ENGLISH) SAYING: "Investors should expect more volatility. So more of the same next year. It doesn't wash away with an interim deal or a tweet or a change in rhetoric. What investors should look for is actual change in actions like a removal or roll back of the existing tariffs and no new tariffs." Shares of online travel agency Expedia among the biggest gainers on the S&P 500. Its CEO and finance head resigned after clashing with the board over strategy. Johnson & Johnson helped lift the Dow. The drug maker said recent tests showed its Baby Powder was free of asbestos. Earlier this year, the FDA reported trace amounts of the material in the product. Shares of Alphabet rallied. Google CEO Sundar Pichai will immediately take over as CEO of the parent company now that Larry Page and Sergey Brin are stepping aside.
